Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Vomiting 1Nausea 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

Dexamethasone 4Therapeutics 3Aprepitant 3Yoga 2Surveys and Questionnaires 2Radiotherapy 2Psychiatric Rehabilitation 2Palonosetron 2Ondansetron 2Gemcitabine 2Fluorouracil 2Analgesia 2isatuximab 1dolasetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1casopitant 1auricularum 1Tropisetron 1Thalidomide 1Taxes 1Radiation 1Oxaliplatin 1Octreotide 1Massage 1Leucovorin 1L 758298 1Irinotecan 1Interviews as Topic 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × dexamethasone acetate × Gastrointestinal × Clear all
NCT02550119 2017-03-28

Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy

University of Southern California

Phase NA Terminated
19 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡